drugset
drugset / Trial / NCT02622685

A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects

NCT02622685 ↗

Phase 1 Completed 58 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedParallel-groupTriple-blindBasic science

Summary

The purpose of this study is to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of DWP10292 and UDCA in healthy male volunteers after multiple-dosing.

Timeline

Start
2015-05
Primary completion
2016-02
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Subject DWP10292 Unknown — Oral
Subject Ursodeoxycholic Acid Small molecule — Oral

Indications

No indication recorded.